These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 16724293

  • 1. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    Iagaru A, Quon A, McDougall IR, Gambhir SS.
    Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.
    Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR.
    Mol Imaging Biol; 2007; 9(1):50-7. PubMed ID: 17051322
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
    Concannon R, Larcos GS, Veness M.
    J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
    [Abstract] [Full Text] [Related]

  • 11. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Ben-Haim S, Garkaby J, Primashvili N, Goshen E, Shapira R, Davidson T, Israel O, Epelbaum R.
    Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, Sari O.
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
    Epstude M, Tornquist K, Riklin C, di Lenardo F, Winterhalder R, Hug U, Strobel K.
    Clin Nucl Med; 2013 Apr; 38(4):283-4. PubMed ID: 23429397
    [Abstract] [Full Text] [Related]

  • 17. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
    Iagaru A, Mittra ES, Gambhir SS.
    Mol Imaging Biol; 2011 Apr; 13(2):362-7. PubMed ID: 20495879
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.